Blog
RSS FeedPosted by Michael Wonder on 29 Aug 2018
Proposal to move to one funded brand of lamotrigine (Logem)
29 August 2018 - PHARMAC is seeking feedback on a proposed change to the funding of lamotrigine dispersible tablets used ...
Posted by Michael Wonder on 28 Aug 2018
Ottawa’s drug-pricing changes threaten Canadians who suffer from rare diseases
28 August 2018 - The federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians with cystic ...
Posted by Michael Wonder on 28 Aug 2018
Cabometyx gets NICE recommendation in renal cell carcinoma
24 August 2018 - French drugmaker Ipsen that it has received a recommendation from NICE for National Health Service funding ...
Posted by Michael Wonder on 28 Aug 2018
Feedback encouraged to allow use of life extending treatment on NHS for those with blood cancer
28 August 2018 - CAR-T considered to be an exciting innovation which can cure some patients but very expensive. ...
Posted by Michael Wonder on 28 Aug 2018
NICE says ‘no’ to Gilead's Yescarta in draft guidelines
28 August 2018 - NHS funding for Gilead’s freshly approved CAR-T therapy Yescarta has been turned down in draft guidelines ...
Posted by Michael Wonder on 27 Aug 2018
Bupa blunder: health insurer pays price for restricting hospital options
27 August 2018 - The biggest health insurer in Australia, Bupa, has admitted the controversial changes it made to paying ...
Posted by Michael Wonder on 27 Aug 2018
Battling cancer and fighting for funding
28 August 2018 - Dr Rosalie Stephens turns up to work these days with hope. ...
Posted by Michael Wonder on 27 Aug 2018
Update on proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)
27 August 2018 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund glecaprevir and ...
Posted by Michael Wonder on 26 Aug 2018
Evidence required by heath technology assessment and reimbursement bodies evaluating diagnostic or prognostic algorithms that include omics data
23 August 2018 - Multi-analyte assays with algorithmic analyses use combinations of circulating and clinical markers including omics-based sources for diagnostic ...
Posted by Michael Wonder on 25 Aug 2018
Ensuring patient voices are heard: how patients can contribute to the CADTH Symposium
24 August 2018 - This webinar will outline the process for submitting abstracts and offer tips and ideas to increase the ...
Posted by Michael Wonder on 25 Aug 2018
Multiple myeloma meeting outcome statement
24 August 2018 - The outcome statement for the multiple myeloma stakeholder meeting held on 23 May 2018 is now available. ...
Posted by Michael Wonder on 23 Aug 2018
Insights from the agenda for the November 2018 PBAC meeting
24 August 2018 - The PBAC will consider 51 submissions at its next scheduled meeting in November. ...
Posted by Michael Wonder on 23 Aug 2018
NICE publishes preliminary guidance on new combo product for AML
23 August 2018 - The Department of Health and Social Care has asked NICE to produce guidance on using liposomal cytarabine ...
Posted by Michael Wonder on 23 Aug 2018
NICE publishes final guidance for dinutuximab
22 August 2018 - Dinutuximab is used to treat children with brain cancer. ...
Posted by Michael Wonder on 23 Aug 2018
Sobi secures NHS reimbursement for Ravicti
23 August 2018 - Rare disease group Swedish Orphan Biovitrum (Sobi) says it has gained NHS England reimbursement for Ravicti ...